Detalhe da pesquisa
1.
Colorectal cancer statistics, 2023.
CA Cancer J Clin
; 73(3): 233-254, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856579
2.
Clinical management of metastatic colorectal cancer in the era of precision medicine.
CA Cancer J Clin
; 72(4): 372-401, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35472088
3.
Current and future cancer staging after neoadjuvant treatment for solid tumors.
CA Cancer J Clin
; 71(2): 140-148, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33156543
4.
Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer.
Proc Natl Acad Sci U S A
; 121(6): e2304619121, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289962
5.
Preoperative Treatment of Locally Advanced Rectal Cancer.
N Engl J Med
; 389(4): 322-334, 2023 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272534
6.
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
N Engl J Med
; 388(18): 1657-1667, 2023 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133585
7.
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.
N Engl J Med
; 386(25): 2363-2376, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35660797
8.
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
Lancet Oncol
; 25(3): 352-365, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423049
9.
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
Lancet Oncol
; 25(3): 338-351, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423048
10.
Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation.
Mol Cancer
; 23(1): 70, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38576002
11.
UGT1A1 genotype-guided irinotecan dosing during neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A prospective analysis of SN-38 concentration.
Int J Cancer
; 154(8): 1484-1491, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38158593
12.
Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohorts.
Int J Cancer
; 154(3): 488-503, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37724848
13.
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
Int J Cancer
; 154(5): 863-872, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840339
14.
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.
Int J Cancer
; 154(10): 1794-1801, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38312102
15.
Inequalities in treatment among patients with colon and rectal cancer: a multistate survival model using data from England national cancer registry 2012-2016.
Br J Cancer
; 130(1): 88-98, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741899
16.
Stromal localization of inactive CD8+ T cells in metastatic mismatch repair deficient colorectal cancer.
Br J Cancer
; 130(2): 213-223, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38042958
17.
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.
Br J Cancer
; 130(8): 1269-1278, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402342
18.
Ondansetron for Low Anterior Resection Syndrome (LARS): A Double-Blind, Placebo-Controlled, Cross-Over, Randomized Study.
Ann Surg
; 279(2): 196-202, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37436844
19.
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Lancet
; 402(10395): 41-53, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331369
20.
Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
Oncologist
; 29(3): e414-e418, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180954